MADISON, WIS., June 30, 2016 – Cellular Dynamics International (CDI), a FUJIFILM company, today announced that the company will host the iForum™ 2016 Meeting: US in Philadelphia from Sept. 12-14 and the iForum 2016 Meeting: Europe in Paris on Oct. 11. Annual iForum events provide attendees with a unique opportunity to connect with thought leaders from academia, government, biotech and pharma to discover new applications and uses for differentiated induced pluripotent stem (iPS) cells. The iForum 2016 Meetings will focus on real-life implementation of human iPS cell technologies. The meetings will include scientific talks, poster sessions, small group roundtables and additional networking opportunities.
MADISON, WIS., June 22, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI), a division of the National Institutes of Health (NIH), to conduct research to advance a cell transplantation therapy for the treatment of retinal degenerative disease using retinal pigment epithelium derived from induced pluripotent stem cells (iPSC-RPE). The collaboration includes the joint development of an optimized biocompatible biodegradable scaffold that is likely to be acritical component for a potential future therapy.
MADISON, WIS., June 21, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced the appointment of Derek Hei, Ph.D., as Vice President of Clinical Manufacture, Quality, and Regulatory activities to lead efforts in support of manufacturing induced pluripotent stem cell (iPSC)-based products for cell therapies. Dr. Hei has over twenty years of experience developing biotherapeutics from research through clinical trials, most recently as director at Waisman Biomanufacturing, a cGMP-compliant manufacturing facility at the University of Wisconsin-Madison.